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Abstract Galactosidases are widespread enzymes that are
used for manifold applications, including production of pre-
biotics, biosynthesis of different transgalactosylated products,
improving lactose tolerance and in various analytical ap-
proaches. The nature of these applications often require ga-
lactosidases to be present in a purified form with clearly
defined properties, including precisely determined substrate
specificities, low sensitivity to inhibitors, and high efficiency
and stability under distinct conditions. In this study, we pres-
ent the recombinant expression and purification of two previ-
ously uncharacterized β-galactosidases from Aspergillus
nidulans as well as one β-galactosidase from Aspergillus
niger. All enzymes were active toward p -nitrophenyl-β-D-
galactopyranoside as substrate and displayed similar temper-
ature and pH optima. The purified recombinant galactosidases
digested various complex substrates containing terminal ga-
lactose β-1,4 linked to either N-acetylglucosamine or fucose,
such as N -glycans derived from bovine fibrin and
Caenorhabditis elegans . In our comparative study of the
recombinant galactosidases with the commercially available
galactosidase from Aspergillus oryzae , all enzymes also
displayed various degrees of activity toward complex
oligosaccharides containing β-1,3-linked terminal galactose
residues. All recombinant enzymes were found to be robust in
the presence of various organic solvents, temperature varia-
tions, and freeze/thaw cycles and were also tested for their
ability to synthesize galactooligosaccharides. Furthermore, the
use of fermentors considerably increased the yield of recombi-
nant galactosidases. Taken together, we demonstrate that puri-
fied recombinant galactosidases from A. niger and from A.
nidulans are suitable for various glycobiological and biotech-
nological applications.
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Introduction
β-Galactosidases (β-D-galactohydrolases, EC 3.2.1.23) are
ubiquitous enzymes capable of hydrolyzing terminal β-D-
galactosyl moieties from substrates such as disaccharides,
diverse glycoconjugates, and polysaccharides. They belong
to the glycoside hydrolase clan A (GH-A), which encom-
passes, among others, β-galactosidase families 35 and 42.
Under distinct reaction conditions, β-galactosidases can also
catalyze transglycosylation reactions using various acceptor
molecules, a capability used for the synthesis of, e.g.,
galactooligosaccharides (GOS) (Park and Oh 2010). β-
Galactosidases have been widely used to hydrolyze lactose
and render dairy products consumable for lactose-intolerant
individuals. Further applications of these enzymes range from
analytical studies (Titz et al. 2009) to glycan remodeling
(Iskratsch et al. 2009) and include various processes of bio-
technological and medical importance (Husain 2010).
The β-galactosidases in general use are mainly derived
from microbial sources, which include both prokaryotic and
eukaryotic organisms. They can be purified at high yields
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directly from fungal organisms (Tanaka et al. 1975; Husain
2010; Sen et al. 2012) or produced in a recombinant form at
high levels in different expression systems (Wang et al. 2009;
Oliveira et al. 2011). Other commonly used sources of β-
galactosidases include bacteria (e.g., bifidobacteria (Hung
et al. 2001; Hsu et al. 2005) and Streptococcus pneumonia
(Hughes and Jeanloz 1964)), yeasts (e.g., Kluyveromyces
lactis (Dickson and Markin 1978)), plants (e.g., from jack
bean (Arakawa et al. 1974; Li et al. 1975)), and animals (e.g.,
bovine testes β-galactosidase (Distler and Jourdian 1973)).
One of the most widely used fungal β-galactosidase orig-
inates from Aspergillus oryzae . As such, detailed data on its
characteristics and many applications have been reported
(Scheckermann et al. 1997; Zeleny et al. 1997; Torres et al.
2003; Vera et al. 2011). The β-galactosidase from Aspergillus
niger was previously used to overcome the Lac− phenotype of
Saccharomyces cerevisiae (Kumar et al. 1992) and its heter-
ologous expression in various yeast hosts as well as its use in
lactose hydrolysis and transgalactosylation reactions was
reviewed recently (Oliveira et al. 2011). A closely related
recombinant β-galactosidase from A. niger van Tiegh has
been recently described as a highly acid-stable enzyme with
prospective use in the treatment of lactose intolerance (Hu
et al. 2010) and a purified native β-galactosidase from this
strain possesses a rather low pH optimum (O’Connell and
Walsh 2010). In 2008, two β-galactosidases secreted by
Aspergillus carbonarius ATCC6276 were purified to homo-
geneity and were shown to be resilient to simulated gastric
conditions (O’Connell and Walsh 2008). Most recently, a β-
galactosidase was purified from Aspergillus alliaceus and
partially characterized; this enzyme, unlike various other fun-
gal galactosidases, has a pH optimum in the neutral range, an
enzymatic property suitable for the preparation of low-lactose
milk (Sen et al. 2012).
Since the Aspergillus spp. are obviously an established
source of robust but different β-galactosidases, we sought to
thoroughly characterize pure forms of recombinant β-
galactosidases using various substrates and conditions. In
addition, as the A. oryzae β-galactosidase only digests termi-
nal β-1,3-linked galactose residues at a very slow rate (Zeleny
et al. 1997), we examined whether any of the galactosidases
from other Aspergillus spp. display higher activity toward
these residues, a feature interesting for glycobiological analy-
ses. In this study, we report on the expression and character-
ization of twoβ-galactosidases fromAspergillus nidulans and
one β-galactosidase from A. niger. We have expressed C-
terminally His-tagged versions of these previously putative
β-galactosidases in Pichia pastoris as an expression host and
purified the recombinant enzymes to apparent homogeneity.
In-depth characterization of the recombinant proteins and
comparison with the commercially available, native galacto-
sidase from A. oryzae were performed. Additionally, we em-
phasized the evaluation of the recombinant enzymes as an
analytical tool, such as for glycobiological analyses, which is
an important application of β-galactosidases rarely evaluated
for novel enzymes. The obtained data show that these recom-
binantβ-galactosidases are promising as reagents for a variety
of glycobiological and biotechnological applications.
Materials and methods
Cloning of sequences encoding Aspergillus β-galactosidases
Open reading frames (ORF) from A. niger (lacA , gene ID
4977988) and A. nidulans (lacA , gene ID 2876531; lacB , gene
ID 2876757) were polymerase chain reaction (PCR) amplified
(Expand Polymerase) from cDNA templates (A. niger
ATCC1015 and A. nidulans A713 strain (Pisanelli et al. 2010))









ATTCGAATATGTAGACG). RNA samples, extracted with
TRIzol reagent (Invitrogen) according to the manufacturer’s
protocol from standard A. niger and A. nidulans cultures, were
kindly provided by Matthias Steiger and Clemens Peterbauer
(both from the University of Natural Resources and Life
Sciences, Vienna, Austria). cDNA was produced from 500 ng
total RNA using the SuperScript III (Invitrogen) reverse tran-
scriptase according to the manufacturer’s guidelines. The PCR
products, which lacked the region encoding the original signal
peptide and native stop codon, were digested with the respective
enzymes (New England Biolabs), ligated (NEB T4 Ligase) in
frame with the digested pGAPZαAvector (Invitrogen), and used
to transform E. coli Top10F′. Positive clones were selected on
LBZeo (25 μg mL−1) plates and the insert sequence was verified
by Sanger sequencing.
Expression in P. pastoris
pGAPZα vectors carrying the ORF of the galactosidases were
linearizedwithDra I and transformed intoP. pastoris X-33 for
secreted expression mediated by the S. cerevisiae α-factor
leader sequence. Positive clones were selected on YPDZeo
(2 % (w /v ) peptone, 1 % (w /v ) yeast extract, 2 % (w /v ) agar,
2 % (w /v ) glucose, 100 μg mL−1 zeocin, pH 7.4) plates and
used for an initial screening in YPDZeo (100 μg mL−1) medi-
um. From 8 to 12 clones, the one with the highest activity in
the culture supernatant was chosen for cultivation in 200 mL
YPD medium (2 % (w /v ) peptone, 1 % (w /v ) yeast extract,
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2 % (w /v ) glucose, pH 7.4) at 25 °C on an orbital shaker at
180 rpm for a total of 48 h. Cultures were supplemented with
an additional 1 % glucose after 24 h.
For large-scale expression of A. niger and A. nidulans
rlacA in fermentors, the cultivation conditions and growth
medium were essentially as described previously (Gasser
et al. 2010). In short, batch cultivations in 1.5 L minimal
mineral medium with glycerol as carbon source were
performed in Minifors (Infors HT) bioreactor units. After a
batch phase of approximately 25 h (25 g L−1 yeast dry mass), a
constant glucose feed at a rate of 0.269 g min−1 was initiated
and performed for a total process time of 100 h (100 g L−1
final yeast dry mass). Temperature was set to 25 °C, diluted
oxygen concentration was kept at 20 % via stirrer speed, and
pH was kept at pH 5.0 by the addition of ammonia throughout
the cultivations. Samples for biomass determination and ac-
tivity assays were taken in regular intervals. For biomass
determination, 5 to 10 mL of culture samples were collected
by centrifugation, washed twice with RO-H2O, and dried to
constant weight at 80 °C.
Protein purification
Galactosidase-expressing P. pastoris clones were cultivated in
10 mLYPGZeo (2 % (w /v ) peptone, 1 % (w /v ) yeast extract,
1 % (w /v ) glycerol, 100 μg mL−1 zeocin, pH 7.4) at 28 °C,
200 rpm on an orbital shaker overnight. From these cultures,
main cultures in 200 mLYPD medium were inoculated at an
OD600=0.05. Cultures were grown at 25 °C, 200 rpm for a
total of 48 h, including feeding with additional 1 % glucose
after 24 h. Cells were harvested by centrifugation at 4 °C and
culture supernatants were collected for protein purification.
All subsequent steps were performed at 4 °C. Culture super-
natants were concentrated using an Amicon ultrafiltration unit
(Millipore) with a 30 kDa NMWL filter (Millipore), followed
by buffer exchange to Ni-NTA column loading buffer (20 mM
Tris, 20 mM NaCl, 5 mM Imidazole, pH 8.5). Protein-
containing solutions were mixed with pre-equilibrated 1 mL
of Ni-NTA agarose slurry (Qiagen) and incubated on a rotator
for 1 h. Then, the mixture was transferred to a plastic column
and, after three washing steps with loading buffer containing
20 mM imidazole (two column volumes per step), recombi-
nant proteins were eluted with 500 mM imidazole (one col-
umn volume per elution fraction). Purity of the recombinant
enzymes was evaluated by Tris–glycine sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE; resolv-
ing gel: T12.5/C1, stacking gel: T5.7/C2.2). Pure fractions
were pooled and imidazole was removed by buffer exchange
to the storage buffer (20 mM Tris–Cl, 25 mM NaCl, pH 7.5)
using Vivaspin columns (30 kDa NMWL; Millipore). All
three recombinant proteins were stored at 4 °C and, as such,
remained active with only minor loss of activity (<15%) for at
least 18 months.
Determination of protein concentration
Protein concentration of purified products was measured after
the removal of imidazole using a bicinchoninic acid protein
quantification kit (Sigma) with bovine serum albumin (BSA)
as standard protein.
Product verification by peptide mass fingerprinting
Tryptic digests were essentially performed as described pre-
viously (Paschinger et al. 2012a). Briefly, protein bands were
cut from Coomassie Brilliant Blue G-250-stained SDS-
polyacrylamide gels and, after several washing steps, “in-
gel” tryptic digestion was performed at 37 °C overnight.
Peptides were released from the gel, dried in a SpeedVac,
and resuspended in 10 μL 50 % acetonitrile/0.1 %
trifluoroacetic acid prior to analysis in positive ion mode on
an Autoflex Speed matrix-assisted laser desorption/
ionization–time of flight mass spectrometer (MALDI-TOF/
TOF MS; Bruker Daltonics) using 1 % α-cyano-4-
hydroxycinnamic as matrix. The obtained list of different m /
z ratios was used to verify protein identity using MS-Fit
(ProteinProspector, UCSF; http://prospector.ucsf.edu/
prospector/mshome.htm).
Removal of N-glycans using PNGase F
Approximately 2 μg of purified recombinant protein was
supplemented with 1 % SDS and incubated at 95 °C for
5 min. After cooling on ice, 0.5 μL PNGase F (glycosidase
F, NEB) or water was added as well as 1× G7 buffer (50 mM
sodium phosphate, pH 7.5) and 1 % NP-40 (Nonidet P-40,
octylphenoxypolyethoxyethanol) in a total volume of 20 μL.
Reactions were incubated at 37 °C for 48 h before Tris–
glycine SDS-PAGE (resolving gel: T12.5/C1, stacking gel:
T5.7/C2.2) and Coomassie Brilliant Blue G-250 staining were
performed.
Enzyme activity assays using p -nitrophenyl-monosaccharides
as substrate
Standard enzymatic activity assays were performed in tripli-
cate with either P. pastoris culture supernatants or purified
products using p -nitrophenyl-β-D-galactopyranoside (PNPG;
Sigma) as substrate. Standard assays were performed at a
substrate concentration of 5 mM in McIlvaine buffer (cit-
rate–phosphate buffer (McIlvaine 1921)), pH 4.5, at 37 °C
in a reaction volume of 40 μL for 2 h. All purified enzymes
were also tested for additional activities using a range of
p-nitrophenyl-sugars as substrates (Table 2). After the addition
of 200 μL of 0.4 M glycine/NaOH pH 10.4, A405 nm was
determined on a Tecan Infinite M200 microtiter plate reader
(Tecan, Austria). Enzymes were appropriately diluted in order
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to measure reactions within the linear range of the assay.
Enzyme units are given in micromoles of product
(nitrophenol) per minute and specific activity as units per
milligram of purified protein.
Determination of the pH optimum, temperature optimum,
temperature stability, and metal ion susceptibility
Tests were performed as described above at 37 °C with 5 mM
PNPG as substrate. McIlvaine buffers with a pH range from 3
to 8 were used. Tests for the determination of temperature
optimum were performed with 5 mM PNPG at different
temperatures in a Gradient PCR Thermocycler (Bio-Rad)
using the McIvaine buffer at the pH determined to be optimal
for the specific galactosidase. For the determination of tem-
perature stability, aliquots of 10 μL of the respective enzyme,
diluted in storage buffer (20 mM Tris–Cl, 25 mM NaCl,
pH 7.5), were incubated at 4, 30, 45, 55, 65, and 75 °C for
2 h. Remaining activity was determined using standard PNPG
assays at 37 °C. For the reactions supplemented with BSA, the
final concentration of BSA was 500 μg mL−1. The effect of
divalent metal ions was tested using the standard PNPG assay
mixtures supplemented with either 1 or 10 mM of the respec-
tive metal chloride salts at 37 °C.
Impact of organic solvents on activity and freeze/thaw
experiments
Diluted enzyme was used in the setup with 5 mM PNPG as
described previously, with the exception that McIlvaine buffer
was partially replaced by acetonitrile, acetone, isopropanol
(IPA), ethanol (EtOH), methanol (MeOH), or RO-H2O to
yield the final concentrations of 0, 10, 25, 50, and 75 % (v /
v ) of the added solvents. The pH of the reaction mixture was
adjusted to the optimal pH of the tested enzyme. For freeze/
thaw experiments, aliquots of galactosidases with a concen-
tration of 100 μg mL−1 (±1 mg mL−1 BSA) were stored in
storage buffer (20mMTris–Cl, 25mMNaCl, pH 7.5) at −20 °C.
After each freeze/thaw cycle, activity was measured using the
standard PNPG assay as described previously.
Determination of Km, specific activity, kcat, and K i
Standard assays were performed at 37 °C inMcIlvaine buffers
of the optimal pH for the respective enzyme. Substrate con-
centrations in the range of 0.1 to 10 mM PNPG were used.
Michaelis constant (Km), specific activity, and kcat were cal-
culated using the nonlinear curve fitting function available in
the OriginPro 8 software package. For K i determination of
galactose, PNGP assays were supplemented with galactose
(1–1,000 mM) and IC50 was calculated based on exponential
curve fitting using OriginPro. K i was calculated based on the
Cheng–Prusoff equation: K i=IC50/(1+[S ]/Km) with IC50
being the half maximal inhibitory concentration of galactose,
[S ] the PNPG concentration (5 mM), and Km the Michaelis–
Menten constant. For Dixon plots (Dixon 1953), standard
assays were performed at 37 °C with PNPG concentrations
of 5, 2.5, and 0.5 mM and supplemented with galactose in the
range of 0 to 50 mM.
Determination of α-mannosidase side activity
2-Aminopyridine (PA)-labeled Man9 (Takara) was used. Ten
picomoles (1 μL) of substrate was mixed with 1 μL MES
pH 4.5 or 6.9 and 0.25 μL 0.2 M CaCl2 and combined with
water and 0.5 μg purified enzyme (1.5 μg in case of A. oryzae
galactosidase) to a total reaction volume of 5 μL. Reactions
were incubated for 16 h prior to analysis by reverse-phase
high-performance liquid chromatography (HPLC) using a
Shimadzu HPLC system equipped with a fluorescence detec-
tor (either RF 10AXL or RF 20AX) and a Hypersil ODS
Column (5 μm, 4×250 mm) equilibrated with 0.1 M ammo-
nium acetate, pH 4.0 (solvent A). Runs were performed at a
flow rate of 1.5 mL min−1 with a 1 % increase of solvent B
(30 % MeOH) per minute for a total of 25 min.




GlcNAc-β-1,4-GlcNAc-β-1-Asn] glycopeptide (0.25 nmol)
derived from bovine fibrin and possessing the common pep-
tide sequence GENR (Gly-Glu-Asn-Arg) (Altmann et al.
1995) was used in a total reaction volume of 10 μL with
galactosidases in McIlvaine buffer pH 4.5. Purified enzyme
(0.2 μg) was added in 24-h intervals. Assays were performed
at 37 °C (or at 50 °C for A. nidulans rlacB) for a total of 120 h
(or 240 h for A. nidulans rlacB). Removal of galactose moi-
eties was monitored in regular intervals on an Autoflex Speed
MALDI-TOF/TOF MS in positive ion mode using 1 % α-
cyano-4-hydroxycinnamic as matrix.
Enzyme activity assays using PA-labeled N-glycan structure
carrying the Galβ1,4Fuc epitope as substrate
PA-labeled N -glycan structure carrying the Galβ1,4Fuc epi-
tope derived from Caenorhabditis elegans (Yan et al. 2012)
was used as substrate. Reactions were performed inMcIlvaine
buffer (pH 4 to 5, i.e., at the optimal pH for each galactosidase
tested) at 37 °C for 24 h with 0.5 μg purified enzyme per assay
and analyzed using an Autoflex Speed MALDI-TOF/TOF
MS in positive ion mode using 0.3 % 6-aza-2-thiothymine
(Sigma) as matrix.
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Determination of β-1,3 and β-1,4 specificity
Fifty micrograms of lacto-N-tetraose [Gal-β-1,3-GlcNAc-β-
1,3-Gal-β-1,4-Glc] and lacto-N -neotetraose [Gal-β-1,4-
GlcNAc-β-1,3-Gal-β-1,4-Glc] (Dextra Laboratories) were la-
beled with PA as described previously (Paschinger et al.
2012b). PA-labeled substrates (final concentration, 40 μM)
were used for enzymatic assays in McIlvaine buffer pH 4.5,
37 °C with 0.5 μg purified enzyme in a total reaction volume
of 10 μL for a total of 48 h. Samples were taken at 2, 24, and
48 h and analyzed by using an Autoflex Speed MALDI-TOF/
TOF MS in positive ion mode using 0.3 % 6-aza-2-
thiothymine (Sigma) as matrix.
Lactose substrate assays and galactooligosaccharide
formation
Lactose was used as substrate at a concentration of 20% (w/v) in
McIlvaine buffer optimal for the respective galactosidase activity
(pH 4 to 5). Four micrograms of purified galactosidase enzyme
was added and reactions were performed in a total volume of
50 μL for 24 h. Samples were taken at 4 and 24 h for analysis by
HPLC (Shimadzu) and an RI detector (Knaur) using a Rezex
RHM column (Phenomenex) with 4 mM H2SO4 as solvent at a
flow rate of 1 mL min−1 at 60 °C. Monosaccharides and disac-
charides used as HPLC standards were purchased from Sigma.
GOS were obtained from Agrana Stärke GmbH, Austria.
A. oryzae β-galactosidase was purchased from Sigma and
purified by cation-exchange chromatography (Zeleny et al.
1997). The DNA sequences of the recombinant galactosi-
dases, as they were obtained in this study, will be available
under the GenBank accession numbers KC175324 (A. niger
lacA ), KC145279 (A. nidulans lacA ), and KC145280
(A. nidulans lacB).
Results
Expression and purification of recombinant galactosidases
For the A. niger lacA and the A. nidulans lacA genes, the
obtained sequences1 matched the sequences deposited in the
NCBI database (GenBank gene IDs 4977988 and 2876531).
Sequence analysis of the PCR products amplified from an A.
nidulans cDNA corresponding to the ORF of the A. nidulans
lacB gene identified in this study revealed small differences
between the amplified transcript1 and the predicted ORF de-
posited in the NCBI database (GenBank gene ID 2876757).
The observed differences are most probably due to improper in
silico prediction of introns and intron splicing sites as the
relevant database entries currently contain only predicted open
reading frames based on the genome of A. nidulans . All three
enzymes contain conserved sequence motifs that are typical for
glycoside hydrolase family 35, a member of the glycoside
hydrolase clan A (GH-A) (Henrissat and Bairoch 1996;
1 The DNA sequences described in this paper will appear in DDBJ, ENA,
and GenBank® Nucleotide Sequence Databases under the accession
numbers KC175324 (A. niger lacA), KC145279 (A. nidulans lacA),
and KC145280 (A. nidulans lacB).
Fig. 1 Galactosidase phenogram and SDS-PAGE analysis of recombi-
nant enzymes. a Protein alignment based on the ClustalW method was
performed in MegAlign 7.2.1 (DNAstar Lasergene software package)
using full-length protein sequences of galactosidases as obtained from the
GenBank database. The phenogram was prepared using the MegAlign’s
built-in phylogenetic tree function. The enzymes described in this study
are indicated by a gray background (including the A. oryzae enzyme used
for comparative purposes). The amino acid sequences with the following
IDs were used: A. niger lacA ID XP_001389622, A. niger ID A2QL84,
A. nidulans lacA ID XP_658360, A. nidulans lacB ID XP_658584, A.
clavatus ID XP_001268843, A. fumigatus ID XP_752787, A. fumigatus
ID XP_748360, A. oryzae ID XP_001727461, Penicilium sp. ID
Q700S9, Trichoderma reesei CAD70669, Homo sapiens ID
NP_000395, K. lactis XP_452194, K. lactis 3OB8_A, and Escherichia
coli ID NP_414878. b SDS-PAGE (Tris–glycine; resolving gel: T12.5/
C1, stacking gel: T5.7/C2.2) analysis of purified recombinant enzymes.
Each galactosidase was obtained free from visible contaminations as
judged by Coomassie Brilliant Blue staining. Purified recombinant pro-
teins were incubated with (+) or without (−) PNGase F to verify whether
they carry N-glycans. MW molecular weight in kilodaltons
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Cantarel et al. 2009). The protein sequence alignment of the
three enzymes (Online Resource 1, Supplemental Fig. S1), as
well as a phylogenetic comparison with other galactosidases
(Fig. 1a), showed that the sequence similarity between the
translated A. niger lacA and A. nidulans lacA ORF is higher,
to each other as compared with the A. nidulans lacB gene
product. After cloning of the three ORF and initial expression
screening, proteins of approximately 130 kDa in size (denoted
as A. niger and A. nidulans rlacA and rlacB hereafter) were
secreted into the supernatant of P. pastoris cultures and could
be detected by Western blotting (via C-terminal Myc/His-tag;
data not shown) and by Coomassie Brilliant Blue staining.
Furthermore, β-galactosidase activity was confirmed in P.
pastoris supernatants using PNPG as substrate, whereas β-
galactosidase activity was absent in the supernatants of control
“empty plasmid” clones. After selection of the best expressing
clone for each recombinant galactosidase, the P. pastoris su-
pernatants were subject to a single-step His-tag affinity batch
purification using Ni-NTA agarose. As judged by SDS-PAGE
analysis, pure proteins were obtained (Fig. 1b). Peptide mass
fingerprinting (tryptic digests followed by MALDI-TOF/TOF
MS analysis) was performed in order to verify the identity of
the recombinant proteins. Sixty-seven to eighty percent of the
tryptic peptides covering 40–51 % protein sequence could be
identified (Online Resource 1, Supplemental Fig. S2). None of
the three recombinant proteins contained tryptic peptides that
would match the secretion signal peptide. This indicates that
signal peptide cleavage by the Kex2 protease occurred correct-
ly. For A. niger rlacA, we observed peptides that contain the
double glutamine–alanine repeat sequence that follows the
Kex2 site. Although not analyzed further, this may indicate
that the cleavage at the glutamine–alanine repeats by the Ste13
protease in P. pastoris is not efficient in the case of A. niger
rlacA, a phenomenon that was reported to occur in a protein-
dependent manner in P. pastoris (Ghosalkar et al. 2008;
Invitrogen 2010). Additionally, each galactosidase contains
several potential N-glycosylation sites (A. niger rlacA has
13, A. nidulans rlacA has 7, and A. nidulans rlacB has
10 putative N-glycosylation sites; Online Resource 1,
Supplemental Fig. S2) and SDS-PAGE analysis shows a smear
suggestive of heterogeneous N-glycosylation of the recombi-
nant proteins (Fig. 1b). Thus, we performed a PNGase F digest
with all three enzymes in order to remove potential
high mannose N -glycan structures typical for P. pastoris
(Hamilton et al. 2006). As expected for glycosylated proteins,
digestion with PNGase F led, due to removal of theN-glycans,
to an increased mobility and a considerable reduction in het-
erogeneity of the protein bands as judged by SDS-PAGE
(Fig. 1b).
Enzyme kinetics and characteristics of recombinant
galactosidases
We determined the basic enzyme kinetic parameters of the
purified recombinant enzymes and compared them with the
native A. oryzae galactosidase (Zeleny et al. 1997), which is
widely used in glycobiotechnological research (Scheckermann
et al. 1997; Torres et al. 2003; Vera et al. 2011). The Km value
of the A. niger rlacA and A. nidulans rlacA galactosidases
toward PNPG was very similar and just below 2 mM, whereas
the other two enzymes (A. nidulans rlacB and A. oryzae
galactosidase) appear to have slightly lower affinity toward this
substrate (Table 1).We also observed up to 30-fold difference in
specific activity among the studied enzymes, with A. niger
rlacA displaying the highest specific activity followed by A.
nidulans rlacA. The low activity of A. nidulans rlacB was
already observed in the initial screening of multiple P. pastoris
clones that expressed the enzyme, as well as in multiple batches
of purified enzyme. Similarly, different batches of the other two
recombinant galactosidases showed consistent Km values and
specific activities (data not shown). Generally, the kinetic
values obtained in this study, and shown in Table 1, are com-
parable to those previously reported for other β-galactosidases
(Park and Oh 2010).
Since various galactosidases were shown to be sensitive to
the presence of divalent metal cations (Tanaka et al. 1975; Sen
et al. 2012), we evaluated the influence of selected metal ions
on the activity of recombinant Aspergillus galactosidases.
Table 1 Properties of Aspergillus β-galactosidases





A. niger rlacA 1.84±0.33 89.3±5.6 195.9±3.6 105.3±15.2
A. nidulans rlacA 1.85±0.21 29.2±1.3 63.4±0.9 34.1±1.5
A. nidulans rlacB 3.33±0.29 2.9±0.1 6.6±0.9 1.9±0.3
A. oryzae β-galactosidasea 3.02±0.61 19.3±1.4 46.4±1.2 14.6±0.6
Km, specific activity, kcat, and kcat/Km (as determined with standard reaction conditions at 37 °C) of purified enzymes using PNPG as substrate are
shown. Values represent averages of three measurements±standard error
a Native A. orzyae galactosidase was obtained commercially and is presented for comparative purposes
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Using PNPG assays supplemented with different metal ions,
we found no clear impact of these ions on the activity of the
studied galactosidases (Online Resource 1, Supplemental
Fig. S3).
For enzyme activity tests, diluted enzymes were used in
order to ensuremeasurements in the linear range.We observed
that the supplementation of the diluted enzymes with BSA
(for all galactosidases) leads to enhanced activity ranging from
two times for A. nidulans rlacB to ten times for A. niger rlacA
(data not shown). The most probable explanation for this
observation are molecular crowding effects of proteins and
solvents, which can have a stabilizing effect on diluted en-
zymes in solution (Homouz et al. 2008; Shen et al. 2009). The
following tests were performed without and with BSA sup-
plementation in order to account for this observation.
In terms of optimal temperature, we observed unexpected
differences among recombinant galactosidases (Fig. 2).
Without BSA supplementation, A. niger rlacA showed a tem-
perature optimum of about 35 °Cwith a very broad temperature
range of activity, showing 60 % activity at temperatures as high
Fig. 2 Temperature and pH optima of Aspergillus galactosidases. The
activity of the Aspergillus galactosidases was measured at various tem-
peratures: a A. niger rlacA, b A. nidulans rlacA, c A. nidulans rlacB, and
d A. oryzae galactosidase. Black squares represent data obtain without
BSA supplementation and open circles represent data obtained with BSA
supplementation (500 μg mL−1 BSA). The activity of the galactosidases
was also measured at various pH values (e): black squares A. niger rlacA,
black circles A. nidulans rlacA, open circles A. nidulans rlacB, open
squares A. oryzae galactosidase. Reactions were performed at 37 °C
(unless otherwise indicated) with 5 mM PNPG as substrate and
0.02 U μL−1 of galactosidase per reaction. All values represent aver-
ages±standard error
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as 70 °C (Fig. 2a). However, the addition of BSA as a stabiliz-
ing agent resulted in a shift of the temperature optimum to
65 °C; this stabilizing effect was also evident when testing the
temperature stability of different batches of A. niger rlacA.
Similar to A. niger rlacA, recombinant lacA from A. nidulans
also showed a rather low temperature optimum of about 30 °C
(Fig. 2b), a result comparable to the previous study on a purified
β-galactosidase from A. nidulans (Díaz et al. 1996); the addi-
tion of BSA also had a stabilizing effect on enzyme activity. A.
nidulans rlacB and A. oryzae galactosidase showed a rather
sharp temperature optimum between 45 and 55 °C irrespective
of the presence of BSA (Fig. 2c, d). We also tested the thermal
stability of the galactosidases and observed that BSA supple-
mentation also had a stabilizing effect on the storage of en-
zymes at low temperatures, whereas at higher temperatures,
BSA does not enhance the stability of the enzymes (Online
Resource 1, Supplemental Fig. S4).
For all recombinant enzymes, the pH optimum was be-
tween pH 4 and 5.5 with both A. nidulans galactosidases
retaining 80 to 90 % of their maximal activity at pH 6
(Fig. 2e). These findings are in contrast with recently reported
lower pH optimum for the homologous protein derived from
A. niger van Tiegh (O’Connell andWalsh 2010) and with data
acquired on a purifiedA. nidulans β-galactosidase, which was
shown to have a pH optimum of 7.5 (Díaz et al. 1996). The
addition of BSA had no significant effect on the pH optima of
the analyzed galactosidases.
For industrial applications in which large amounts of prod-
ucts accumulate, the tolerance of recombinant enzymes to-
ward high product concentrations is a critical factor (Vera et al.
2011). We used standard PNPG assays, supplemented with
different amounts of either glucose or galactose (as products
from, e.g., lactose digestion), in order to investigate product
inhibition. We found that all enzymes, including A. oryzae
galactosidase, were strongly inhibited by galactose but not by
glucose (Online Resource 1, Supplemental Table S1). A.
nidulans rlacA proved to be the least inhibited by galactose,
as it is also indicated by the calculatedK i values for galactose:
K i=3.0, 10.2, 1.4, and 0.6 mM for A. niger rlacA, A. nidulans
rlacA, A. nidulans rlacB, and A. oryzae galactosidase, respec-
tively. In order to further analyze the mode of enzyme inhibi-
tion by galactose, additional enzymatic assays with different
substrate (PNPG) and galactose concentrations were
performed. As expected, Dixon plots indicated that galactose
acted as competitive inhibitor on all enzymes in this study
(data not shown).
Substrate specificity of recombinant galactosidase
preparations
p -Nitrophenyl derivatives also serve as good substrates in
quickly screening enzyme activity. Thus, we used ten different
p -nitrophenyl substrates in order to test the recombinant
enzyme preparations for potential activities toward other ter-
minal monosaccharide residues, which, for example, could
derive from contaminations with P. pastoris proteins. We
show that the enzyme preparations exhibited extremely weak
or negligible activity toward other substrates than PNPG and
thus possess very high purity (Table 2).
In order to appraise the analytical value of these enzymes,
we also tested several potential “natural” substrates: a glyco-
peptide containing a biantennary N-glycan with two terminal
galactose residues, two tetrasaccharides having either β-1,3-
linked or β-1,4-linked terminal galactose residues (lacto-N-
tetraose and lacto-N-neotetraose) and an N-glycan structure
with β-1,4-linked galactose attached to a core α1,6-linked
fucose (the N-glycan containing the “Galβ1,4Fuc” epitope).
In addition, we tested whether the preparations of recombinant
galactosidase act on an oligomannosidic structure with nine
mannose residues.
N-glycans as substrates for Aspergillus galactosidases
The dabsylated-GalGal glycopeptide derived from bovine
fibrin carries two terminal galactose residues. The assays with
the dabsylated-GalGal glycopeptide show that A. niger rlacA
can be used to trim the galactose moieties from the substrate.
Approximately 5 % of the galactose residues, as estimated
from the MALDI-TOF/TOF MS data, were not cleaved, al-
though assays were incubated for up to 96 h with additional
enzyme being added every 24 h (Fig. 3a). Since it has been
estimated that roughly 95 % of the galactose on the
Table 2 Activity of recombinant galactosidase preparations toward sub-
strates not having a terminal β-galactose residue
Percent activity A. niger rlacA A. nidulans rlacA A. nidulans rlacB
β-Galactose 100 100 100
α-Galactose <0.01 <0.1 <0.5
α-Glucose <0.1 0 <2.0
β-Glucose <0.1 <0.1 <2.0
α-Xylose <0.05 0 <2.0
β-Xylose <0.1 <0.05 <2.0
α-GlcNAc 0 <0.05 <0.15
β-GlcNAc 0 <0.05 <0.1
α-GalNAc 0 <0.01 0
β-GalNAc ND 0 <1.0
α-Mannose 0 0 <0.5
Activities were determined with different p-nitrophenyl substrates in
standard reaction conditions for 4 h. Values are given in percent, with
PNPG substrate defined as 100 % activity
ND not determined, GlcNAc N -acetylglucosamine, GalNAc N -
acetylgalactosamine
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glycopeptide are β-1,4-linked, whereas the residual 5 % are
β-1,3-linked (Pabst et al. 2007), the assays indicate a strict β-
1,4 specificity of A. niger rlacA under these conditions. The
residual 5 % of the galactose residues could be removed by
addition of bovine testes β-galactosidase known to trim β-
1,3-linked galactose residues (Distler and Jourdian 1973).
Similar to A. niger rlacA, A. nidulans rlacA and rlacB could
also be used for the removal of galactose from the fibrin-
derived dabsylated-GalGal glycopeptide. However, in con-
trast to A. niger rlacA, A. nidulans rlacA removed almost all
Fig. 3 Complex N-glycans as substrates for recombinant galactosidases.
Dabsylated-GalGal glycopeptide derived from bovine fibrin was used as
substrate for a A. niger rlacA and b A. nidulans rlacA. Additional
enzyme (0.2 μg) was added every 24 h. An approximate amount of
5 % non-cleavable galactose, which corresponds to β-1,3-linked
galactose remained in the A. niger rlacA reactions (a) and could be
successfully removed upon the addition of bovine testes galactosidase
at 96 h. The glycans are depicted following the glycan nomenclature of the
Consortium for Functional Glycomics (http://www.functionalglycomics.org)
Fig. 4 β-1,3 activity of recombinant galactosidases. PA-labeled lacto-N-
neotetraose (contains terminal β-1,4-Gal) (a) and lacto-N-tetraose (con-
tains terminal β-1,3-Gal) (b) were used as substrates for recombinant and
native galactosidases (0.5 μg of each enzyme was used). After 24 h
incubation, reactions were analyzed by MALDI-TOF/TOF MS.
Hydrogen (m /z 786.3 and 624.2) as well as sodium adducts (m /z 808.3
and 646.2) were detected. The removal of galactose resulted in Δm /z
162 Da. The glycans are depicted following the glycan nomenclature of the
Consortium for Functional Glycomics (http://www.functionalglycomics.org)
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galactose residues (0.4 % remaining) within 96 h, indicating a
β-1,3 hydrolyzing activity of this galactosidase (Fig. 3b). Due
to the low efficiency ofA. nidulans rlacB, higher temperatures
and longer incubation times were necessary to achieve the
same degree of substrate conversion and, similar to A. niger
rlacA, no cleavage ofβ-1,3-galactose residues from the fibrin-
derived dabsylated-GalGal glycopeptide occurred (data not
shown).
β-1,3 hydrolyzing activity of recombinant and native
galactosidases
To further address the β-1,4 and β-1,3 specificity of the
recombinant enzymes, pyridylaminated forms of lacto-N -
tetraose [Gal-β-1,3-GlcNAc-β-1,3-Gal-β-1,4-Glc] and
lacto-N -neotetraose [Gal-β-1,4-GlcNAc-β-1,3-Gal-β-1,4-
Glc] were tested as substrates. As judged by MALDI-TOF/
TOF MS analyses, all three recombinant enzymes, as well as
the native galactosidase from A. oryzae , accept both linear
substrates, although with different efficiencies (Fig. 4 and
Supplemental Table S2). Although in most studies this aspect
of family 35 β-galactosidases is not addressed, these findings
are in line with the data on purified β-galactosidase from A.
niger, which was shown to act, among others, on Gal-β-1,3-
Gal-β-PNP, Gal-β-1,3-Gal-α-PNP, and to lesser extent,
Gal-β-1,3-GalNAc/GlcNAc substrates (Sykes et al. 1983).
Other tests on pyridylaminated N -glycans
In the experiments described previously, we could show that
the recombinant galactosidases remove terminal galactose
residues linked to N -acetylglucosamine (either from a
branched biantennary N -glycan or a linear tetrasaccharide).
Studies on some invertebrate N-glycans clearly demonstrate
the existence of structures carrying galactose residues also
directly β-1,4-linked to fucose (Galβ1,4Fuc epitope (Zhang
et al. 1997b; Yan et al. 2012)). Using a PA-labeled substrate
and MALDI-TOF/TOF MS analysis of the assays, we show
that all three recombinant galactosidases were able to catalyze
the removal of the galactose residue from the Galβ1,4Fuc
epitope (Fig. 5 and Online Resource 1, Supplemental
Fig. S5). In agreement with all previous tests, despite equal
amounts of protein used, A. nidulans rlacB showed incom-
plete conversion due to lower efficiency of this enzyme.
As a final test of purity, we also tested preparations of both
native and recombinant enzymes for potential mannosidase
activity using PA-labeled oligomannosidic Man9, since p -
nitrophenyl-mannoside is often poorly accepted by α1,2-
mannosidases as a substrate (Forsee et al. 1989). Any
mannosidase activity present in galactosidase preparations
would be detrimental for the potential use in mass spectromet-
ric N-glycan analyses, in which the analyzed glycans contain
both mannose and galactose as terminal residues, since these
monosaccharides have the samemass (162.14 Dawhen bound
to a glycan). Indeed, class I mannosidase activity was ob-
served when using commercially available, native A. oryzae
galactosidase (Online Resource 1, Supplemental Fig. S6). In
contrast, α1,2-mannosidase activity was not observed in the
preparations of recombinantly produced and purified
Aspergillus enzymes (Online Resource 1, Supplemental
Fig. S6), indicating the successful removal of endogenous
P. pastoris mannosidases during protein purification.
Lactose as substrate and galactooligosaccharide formation
by galactosidases
We tested whether lactose is accepted as substrate and whether
using lactose as a substrate could lead to GOS formation. At a
lactose concentration of 20 %, all three recombinant galactosi-
dases could be successfully used to hydrolyze lactose. After 4 h
of incubation, additional peaks were detected, which co-eluted
with trigalactooligosaccharides and tetragalactooligosaccharides
in a commercial GOS preparation. Prolonged incubation for 24 h
leads to degradation of GOS and lactose to glucose and galac-
tose. The conversion efficiency to monosaccharides of the three
recombinant enzymes was in agreement with the specific activ-
ities that were also observed for PNPG as substrate; A. niger
rlacA showed the highest efficiency, followed by A. nidulans
rlacA and rlacB (Online Resource 1, Supplemental Fig. S7).
Stability of recombinant galactosidases
For certain industrial applications such as transgalactosylation
other than GOS formation, substantial amounts of organic
solvents might be present in a reaction mixture in order to
dissolve the substrate (Scheckermann et al. 1997). We exam-
ined the influence of organic solvents including acetonitrile,
acetone, IPA, EtOH, and MeOH on the enzymatic activity
using PNPG assays. The data obtained show that all three
recombinant galactosidases retained high activity with con-
siderably high amounts of these solvents; A. niger rlacA
displayed the highest tolerance (Online Resource 1,
Supplemental Fig. S8). Interestingly, in some cases, the
highest enzymatic activity was observed at intermediate or-
ganic solvent concentrations. This effect, similar to the addi-
tion of BSA to the diluted enzyme, can be explained by
refolding of partly misfolded protein and its subsequent stabi-
lization induced either by molecular crowding effects or sim-
ply by altered properties of the solution (Homouz et al. 2008;
Shen et al. 2009). In contrast, the addition of pure water to
dilute the buffer, instead of organic solvent, had a minor effect
on enzyme activity (Online Resource 1, Supplemental
Fig. S8).
As described in the “Materials and methods” section, all
three preparations of recombinant, purified galactosidases
could be stored as concentrated enzyme solutions at 4 °C for
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18 months without major loss of activity (<15 %), indicating
high stability. In order to further investigate the stability of the
enzymes, we performed freeze/thaw experiments and show
that all Aspergillus galactosidases, including the nonrecombi-
nant A. oryzae galactosidase, could withstand at least ten
freeze/thaw cycles without major loss of enzymatic activity
(Online Resource 1, Supplemental Fig. S9). The enzymes
were stable at a concentration of 100 μg mL−1 without the
addition of glycerol as a cryoprotective agent. Furthermore, no
significant positive effect of BSA supplementation to the
storage solution for protein stability was observed.
Scale-up of A. niger rlacA and A. nidulans rlacB expression
The use of P. pastoris as an expression host followed by one-
step His-tag purification was found to be an excellent choice
for recombinant expression and subsequent purification of
fungal β-galactosidases. Efficient low-cost production of re-
combinant proteins with high yields is of great importance,
especially for enzymes of potential industrial use. As estimat-
ed by the specific activity of the purified enzymes, yeast
culture supernatants contained recombinant protein in a con-
centration of more than 100 μg mL−1 after 48 h of growth in
shaker flasks without optimization of the culture conditions at
low cell densities in complex medium. For P. pastoris as
expression host, high cell densities can be achieved in fermen-
tors in defined minimal medium; however, cultivation in
minimal medium can also come at the cost of lower yields
of recombinant protein as compared with complex medium
(Macauley-Patrick et al. 2005). To examine this, we
performed pilot expressions with A. niger rlacA and A.
nidulans rlacA expressing P. pastoris clones in fermentors.
We did not perform expression of A. nidulans rlacB in fer-
mentors, since the characterization of this enzyme indicated
limited value for glycobiotechnological and biotechnological
applications. A simple linear glucose feed protocol aiming at a
final yeast dry mass of 100 g L−1 and a total process time of
100 h resulted in very high recombinant protein titers with up
to approximately 3.5 and 0.2 g L−1 of recombinant protein for
A. niger rlacA and A. nidulans rlacA, respectively (Online
Resource 1, Supplemental Fig. S10).
Discussion
In this study, we cloned, expressed, purified, and analyzed
properties of two previously uncharacterized β-galactosidases
from A. nidulans and of the homologous enzyme from A.
Fig. 5 Unusual galactose-carrying N-glycan structures as substrates. A
PA-labeledN-glycan structure carryingGalβ1,4Fuc epitope was tested as
a substrate for recombinant galactosidases (a no enzyme, b A. niger
rlacA, c A. nidulans rlacA, and d A. nidulans rlacB; 0.5 μg of each
enzyme was used). The substrate has an m /z of 1,500.5 (hydrogen
adduct) and 1,522.5 (sodium adduct), whereas the product has an
expectedm /z of 1,338.5 (hydrogen adduct) and 1,360.5 (sodium adduct).
AdditionalMS/MS spectra show that the 162-Da loss attributes to the loss
of the galactose moiety and not a mannose moiety (Online Resource 1,
Supplemental Fig. S5). The glycans are depicted following the glycan
nomenclature of the Consortium for Functional Glycomics (http://www.
functionalglycomics.org)
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niger previously expressed in various systems optimized for
high-yield protein production (Oliveira et al. 2011) and used to
study Lac− phenotype of S. cerevisiae (Kumar et al. 1992). The
previously uncharacterized aspects of these three enzymes are
compared to those of the commercially available, native en-
zyme from A. oryzae . We demonstrate that one of the recom-
binant enzymes, A. nidulans rlacA, has a number of exception-
al properties, including reduced inhibition by galactose (K i=
10.2 mM) and an increased activity toward β-1,3-linked termi-
nal galactose (Fig. 3 and Online Resource 1, Supplemental
Table S2). The enzymes were essentially free from other gly-
cosidase activities (including α1,2-mannosidase activity) and
performed up to ten times better when incubated in presence of
BSA. As such, these enzymes are suitable for a wide range of
applications. On the other hand, the A. nidulans rlacB
underperformed in most aspects tested in this study.
To date, none of the β-galactosidases were shown to have
absolute specificity toward either terminal β-1,3-linked, β-1,4-
linked, or β1,6-linked galactose. Most β-galactosidases (the
ones from E. coli , A. oryzae , Canavalia ensiformis (jack
beans), and S. pneumoniae) strongly prefer terminal β-1,4-
linked galactose; these enzymes were also shown to process
terminal β-1,3-linked galactose, albeit at a very low rate
(Zeleny et al. 1997). On the other hand, bovine testes β-
galactosidase prefers terminal β-1,3-linked galactose, but can
also process β-1,4-linked galactose efficiently (Distler and
Jourdian 1973). Accordingly and similar to A. niger rlacA
described in this study (Fig. 3), A. oryzae β-galactosidase
activity towardβ-1,3-galactose residues has proven insufficient
for complete degalactosylation of a bovine fibrin-derived
dabsylated-GalGal glycopeptide (Mucha et al. 2004).
However, A. nidulans rlacAwas shown here to have increased
preference toward β-1,3-linked galactose and to possess the
ability to remove β-1,3-linked galactose residues from the
dabsylated-GalGal glycopeptide (Fig. 3 and Online Resource
1, Supplemental Table S2). In addition, this enzyme has already
been used for the removal of terminal β-1,3-linked galactose
from oyster (hybrid) N -glycans in our laboratory (K.
Paschinger, personal communication).
The β-galactosidases also differ in their ability to process
terminally galactosylated structures according to an N -glycan
backbone. Recently, it was shown that C. ensiformis galacto-
sidase is not able to remove galactose β-1,4-linked to a core
fucose residue, a structure found in many species belonging to
Protostomia, whereas S. pneumoniae galactosidase could di-
gest that epitope (Takeuchi et al. 2011). All recombinant
enzymes tested in the current study were shown to be able to
remove galactose β-1,4-linked to a core fucose residue. The










The analyses performed in this study are labeled with gray background
n/d not determined, + activity detected, − activity not detected, GP glycopeptide
a Takeuchi et al. (2011)
b Zeleny et al. (1997)
cMucha et al. (2004)
d Titz et al. (2009)
e Distler and Jourdian (1973)
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activities displayed by recombinant and native Aspergillus β-
galactosidases in comparison to other commonly used β-
galactosidases in glycan analyses are summarized in Table 3.
Using high lactose concentrations for our assays to test the
ability for lactose hydrolysis, we could show that all three
recombinant enzymes were able to accept lactose as a sub-
strate, although with large differences in terms of their effi-
ciency. The commercialA. oryzae β-galactosidase has already
been used in multiple studies on lactose hydrolysis and GOS
production (Iwasaki et al. 1996; Park and Oh 2010; Guerrero
et al. 2013). The kinetics of the GOS production process de-
mand that the amount of enzyme, the lactose concentration, and
the reaction conditions, such as temperature, pH, and reaction
time, are tightly controlled in order to allow for efficient synthe-
sis (Vera et al. 2011; Palai et al. 2012). In line with the dynamics
of GOS production, we observed the appearance of GOS after
4 h of incubation with an initial lactose concentration of 20 %
and their subsequent degradation after prolonged incubation for
24 h (Online Resource 1, Supplemental Fig. S7) It is beyond the
scope of the current study to optimize the GOS production
conditions; however, these initial results highlight that A. niger
rlacA and A. nidulans rlacA are suitable for such a process in
principle and may also serve for other transglycosylation reac-
tions that aremediated byβ-galactosidases such as, for example,
antibiotics and PEG transglycosylation (Scheckermann et al.
1997; Fang et al. 2012) as these enzymes tolerate fairly high
amounts of organic solvents.
In order to improve the cost-effectiveness of large-scale
industrial applications for lactose hydrolysis and GOS produc-
tion, various immobilization strategies, such as the immobiliza-
tion on amino-epoxy beads, magnetic beads, and cotton cloth,
were already applied for β-galactosidases (Albayrak and Yang
2002; Torres et al. 2003; Zhang et al. 2010); altogether, these
immobilization strategies have been successful as they increase
the operational, thermal, and pH robustness of the enzymes
(Klein et al. 2013) and are, as such, beneficial for continuous
bioprocesses (Liu et al. 2012). Considering the generally high
thermal stability ofA. niger andA. nidulans rlacA, it will also be
of great interest to explore different immobilization strategies for
these novel enzymes in future projects.
Moreover, β-galactosidases have also been successfully
engineered in order to achieve decreased product inhibition by
galactose (Hu et al. 2010; Kim et al. 2011). In this regard, A.
nidulans rlacA may be, due to its generally high K i for galac-
tose, a very interesting and suitable candidate for future protein
engineering studies. The availability of crystal structures of
closely related enzymes, including the recently reported struc-
ture ofA oryzae β-galactosidase (Maksimainen et al. 2013)may
further facilitate not only the directed engineering of fungal
galactosidases toward decreased product inhibition but also the
engineering toward other relevant improved activities such as
glucuronidase (Xiong et al. 2007), fucosidase (Zhang et al.
1997a), or glycosynthase activity (Shim et al. 2012).
Large-scale processes demand large quantities of enzyme,
and the use of immobilized enzymes proved successful in
order to improve the economics of such processes. In the
current study, high yields of these prospective enzymes could
be achieved by using the P. pastoris GAP promoter system
and fermentor cultivation (Online Resource 1, Supplemental
Fig. S10). Whereas we only used minimal medium, yields
may be further increased by growth medium optimization and
the addition of proper feed supplements (Pal et al. 2006) or
altered process conditions and advanced feed strategies that
already proved successful for GAP promoter-based protein
production processes in P. pastoris (Maurer et al. 2006;
Baumann et al. 2008). Nevertheless, according to our fermen-
tor experiments, cost-effective large-scale production of these
novel recombinant galactosidases is certainly feasible.
All three enzymes in the current study share predicted β-
galactosidase protein domains, and we could verify this hydro-
lytic activity. A. niger and A. nidulans rlacA could be success-
fully applied in order to process lactose and N-glycan sub-
strates. Nevertheless, A. nidulans rlacB showed the weakest
performance on all substrates that were tested. As the ORF used
for expression did not completely match the predicted one, we
cannot exclude the possibility that this discrepancy influences
the catalytic activity of this enzyme. In their natural habitat,
fungi subsist to some extent on the degradation of plant material
and are a valuable source for polysaccharide-degrading en-
zymes (van den Brink and de Vries 2011). Furthermore, fila-
mentous fungi also produce β-galactosidases when grown on
substrates such as polygalacturonic acid (McKay 1991). In this
context, it is possible that neither of the tested compounds
represents a natural substrate for the A. nidulans rlacB enzyme.
In conclusion, with the potential of low-cost and efficient
large-scale production and ease of purification, recombinant
galactosidases from A. niger and A. nidulans (rlacA) enrich
the series of valuable β-galactosidase enzymes available for
various biotechnological and analytical procedures andmay also
serve as potential targets for glycoenzyme engineering studies.
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